Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Philadelphia Chromosome 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Blast Crisis 1

Interventions

Cyclophosphamide 28 Rituximab 23 fludarabine 14 fludarabine phosphate 12 Specimen Handling 11 obinutuzumab 10 ibrutinib 10 Magnetic Resonance Spectroscopy 10 Prednisone 8 Doxorubicin 8 tocilizumab 7 polatuzumab vedotin 7 X-Rays 7 Whole-Body Irradiation 7 Phantoms, Imaging 7 Mycophenolic Acid 7 Etoposide 7 Biopsy 7 venetoclax 6 glofitamab 6 Melphalan 6 Lenalidomide 6 Bendamustine Hydrochloride 6 pirtobrutinib 5 acalabrutinib 5 Vincristine 5 Peripheral Blood Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 Nivolumab 5 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × bosutinib × 90 days × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡